Home · Learn · Paths · Post-Market Track
Learning path

Post-Market Track

Your device is on the market. Stay compliant. Survive inspections. Avoid recalls.

For teams operating post-clearance - recalls, MDR, surveillance, inspections, warning letters, QMSR.

Audience. Quality leads, RA leads at commercial-stage medtechs, compliance officers.6 chapters · ~96 min · 12 articles
  1. 1
  2. 2

    Adverse event reporting (MDR)

    When you must report, what counts as MDR-reportable, the 30-day and 5-day clocks.

  3. 3

    Inspections and Form 483

    Front-room/back-room playbook, the 483 response window, and what 'not committing' really means.

  4. 4

    Warning letters - prevent, decode, respond

    Reading FDA's signal, drafting the response, and the operational fixes that close the file.

  5. 5
  6. 6

    The QMSR transition (Feb 2026)

    What changes under QMSR, what stays, and the gap analysis you need to run now.

End of path

You finished the Post-Market Track.

Want to keep going? Browse every explainer tagged for this track, or jump into another path.